Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 481-484

  Spangler, S K ^a   Jacobs, M R ^b   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFDINIR; CEFDITOREN PIVOXIL; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EPEREZOLID; ERYTHROMYCIN; IMIPENEM; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; RIFAMPICIN; RPR 106950; RPR 106972; RPR 112808; SPARFLOXACIN; STREPTOGRAMIN DERIVATIVE; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN; VIRGINIAMYCIN M2;

ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; BRONCHITIS; MINIMUM INHIBITORY CONCENTRATION; OTITIS MEDIA; PRIORITY JOURNAL; PRISTINAMYCIN IB; SINUSITIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ACETAMIDES; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OXAZOLES; OXAZOLIDINONES; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE; VIRGINIAMYCIN;

EID: 0030034825     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.481     Document Type: Article

References (27)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis 15:77-83.
2. Barry, A. L., M. A. Pfaller, P. C. Fuchs, and R. R. Packer. 1994. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:2419-2425.
3. Berthaud, N., Y. Charles, A.-M. Gouin, B. Méreau, J. Rousseau, and J.-F. Desnottes. 1995. RPR 106972, a new oral streptogramin. in vitro antibacterial activity, abstr F112, p. 132. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Block, S., J. Hedrick, P. Wright, R. Finger, R. Leggiadro, M. Appleton, S. Kahn, and R. Hutcheson. 1994. Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee, 1993. Morbid. Mortal. Weekly Rep. 43:23-25, 31.
5. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
6. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, S. A. Garmon, K. C. Grega, S. K. Hendges, P. R. Manninen, D. S. Toops, D. A. Ulanowicz, J. O. Kilburn, S. Glickman, G. E. Zurenko, and C. W. Ford. 1995. Synthesis of U-100592 and U-100766, two new oxazolidinone antibacterial agents in clinical trials for treatment of multiply resistant gram positive infections, abstr. F208, p. 149. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Canton, R., J. Liñares, J. Martinez-Beltran, F. Tubau, F. Almaraz, F. Alcaide, and F. Baquero. 1994. Bactericidal activity of cefditoren (ME-1206) on Streptococcus pneumoniae and Streptococcus of the viridans group, abstr E11, p. 28. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D.C.
8. Dowzicky, M. (Rhône-Poulenc Rorer Pharmaceuticals, Inc.). 1995. Personal communication
9. Fremaux, A., G. Sissia, I. Brumpt, and P. Geslin. 1993 Cefditoren (ME-1206), a new cephalosporin: in vitro activity against penicillin susceptible and resistant pneumococci, abstr 998, p. 289. In Abstracts of the 18th International Congress on Chemotherapy, 1993.
10. Fremaux, A., G. Sissia, M. Rosembaum, and P. Geslin. 1992. In vitro activity of cefpirome (HR 810), a new parenteral cephalosporin, against penicillin susceptible and resistant pneumococci, abstr. 1020, p 280. In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D.C.
11. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae N. Engl J. Med. 331:377-382.
12. Goldstein, F. W., P. Geslin, J. F. Acar, and the French Study Group. 1994 Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistant Streptococcus pneumoniae. Eur. J. Clin Microbiol. Infect. Dis. 13:33-34
13. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
14. Liñares, J., T. Alonso, J. L. Pérez, J. Ayats, M. A. Domínguez, R. Pallarés, and R. Martín. 1992. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J Antimicrob. Chemother. 30: 279-288.
15. Liñares, J., R. Pallares, T. Alonso, J. L. Perez, J. Ayats, F. Gudiol, P. F. Viladrich, and R. Martin. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99-105
16. Miyazaki, S., Y. Miyazaki, A. Tsuji, M. Nishida, and S. Goto. 1991. In vitro antibacterial activity of ME1207. a new oral cephalosporin. Antimicrob. Agents Chemother. 35:1691-1694.
17. National Committee for Clinical Laboratory Standards. 1994 Performance standards for antimicrobial susceptibility testing. NCCLS publication no. M100-S4. National Committee for Clinical Laboratory Standards, Villanova. Pa.
18. Negri, M. C., M. I. Morosini, E. Loza, and F. Baquero. 1994. In vitro selective concentrations of cefditoren for penicillin resistant Streptococcus pneumoniae populations, abstr. E15, p. 28. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
19. Nelson, C. T., E. O. Mason, Jr., and S. L. Kaplan. 1994. Activity of oral antibiotics in middle car and sinus infections caused by penicillin-resistant Streptococcus pneumoniae. implications for treatment. Pediatr Infect Dis. J 13:585-589.
20. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1994. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology Antimicrob. Agents Chemother. 38:2065-2072.
21. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1995. Comparative activity of ampicillin, amoxycillin, amoxycillin/davulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. J. Antimicrob. Chemother. 35:883-888.
22. Pawsey, S. D., J. D. Harry, and D. J. Stalker. 1995. 1st administration of a new oxazolidinone antibiotic (U-100592) to man, abstr. F225, p. 152. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D.C.
23. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawada, P. T. Bartholemew, W. A. Gregory, and M. Forbes. 1987 Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrob. Agents Chemother. 31:1791-1797.
24. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1992. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, Win 57273, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36:856-859.
25. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1994. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Antimicrob. Agents Chemother 38:2902-2904.
26. Spangler, S. K., M. R. Jacobs, G. A. Pankuch, and P. C. Appelbaum. 1993 Susceptibility of 170 penicillin-susceptible and -resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. J. Antimicrob. Chemother. 31:273-280.
27. Tweardy, D. J., M. R. Jacobs, and W. T. Speck. 1983. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials; implications for treatment of meningitis. J. Antimicrob. Chemother. 12:133-139.